Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Selkirk Pharma Appoints New Head of Quality | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Selkirk Pharma Appoints New Head of Quality

Sandra Lueken has assumed the role of Vice President, Head of Quality & Regulatory Affairs.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Selkirk Pharma, Inc., a privately held U.S. pharmaceutical manufacturer, has named Sandra Lueken to the role of Vice President, Head of Quality and Regulatory Affairs.

In this role, she will join Selkirk’s executive leadership team and oversee all Quality Unit and Regulatory Affairs functions at the company. Over the past twenty years, Ms. Lueken has held senior level positions in Quality at StrideBio, KBI Biopharma, AstraZeneca, Medimmune, Baxter Biopharma, and HollisterStier.

“Sandra has a rare combination of skill, experience, humility, and passion for patient care,” said Patrick Haffey, CEO of Selkirk. “We are grateful to have her on our team during such an important time for our company.”

Ms. Lueken joins Selkirk just as the company completes construction of its first manufacturing line. She will now oversee commissioning and operational ramp up activities.

Selkirk was founded in 2018 and provides manufacturing (fill and finish) services for injectable drug products, with an emphasis in biologics.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics